FDA Inspection 1103335 — Prof. Mariusz Kruk, M.D. Ph.D.

Prof. Mariusz Kruk, M.D. Ph.D. — FEI 3015403181

The FDA completed an inspection of Prof. Mariusz Kruk, M.D. Ph.D. on September 13, 2019 in Warsaw. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warsaw (Poland)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate